Results 81 to 90 of about 344,680 (247)
Multiple myeloma (MM) is a plasma cell malignancy considered incurable despite the recent therapeutic advances. Effective targeted therapies are therefore needed.
Yao Yao +7 more
doaj +1 more source
Investigation of urinary proteins in multiple myeloma by means of salting-out analysis [PDF]
Elizabeth P. Steyn-Parvé +1 more
openalex +1 more source
Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease [PDF]
The proteasome is the central component of the main cellular protein degradation pathway. During the past four decades, the critical function of the proteasome in numerous physiological processes has been revealed, and proteasome activity has been linked
Li, Jing, Sherman, David J.
core
Multiple-Myeloma proteins.I. Immunological studies [PDF]
Leonhard Korngold, Rose Lipari
openalex +1 more source
Daratumumab induces CD38 internalization and impairs myeloma cell adhesion
Daratumumab (Dara), a human immunoglobulin G1 kappa (IgG1κ) monoclonal anti-CD38 antibody, has been approved by the U.S. Food and Drug Administration for the treatment of relapsed multiple myeloma (MM) as a single agent as well as in combination with ...
Jayeeta Ghose +17 more
doaj +1 more source
Multiple myeloma (myelomatosis) with Bence‐Jones proteid in the urine (myelopathic albumosuria of Bradshaw, Kahler's disease.) [PDF]
F. Parkes Weber
openalex +1 more source
FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA [PDF]
Alexander B. Gutman +4 more
openalex +1 more source
A CASE OF MULTIPLE MYELOMA, [PDF]
OwenT Williams, EA. Evans, Ernest Glynn
openalex +1 more source

